tedizolid phosphate (sivextro) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$277.8227 - $2211.0200

VA FSS

$288.0167 - $2294.2200

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tedizolid phosphate 200 mg (TABLET) $277.8227 VA Big4
  • SIVEXTRO (30)
    		•  Merck Sharp & Dohme Corporation
    tedizolid phosphate 200 mg (TABLET) $288.0167 VA FSS
  • SIVEXTRO (30)
    		•  Merck Sharp & Dohme Corporation
    tedizolid phosphate 200 mg (TABLET) $1653.8300 VA Big4
  • SIVEXTRO (1)
    		•  Merck Sharp & Dohme Corporation
    tedizolid phosphate 200 mg (TABLET) $1728.0700 VA FSS
  • SIVEXTRO (1)
    		•  Merck Sharp & Dohme Corporation
    tedizolid phosphate 200 mg / 4 mL (4 mL INJECTION) $2211.0200 VA Big4
  • SIVEXTRO (1)
    		•  Merck Sharp & Dohme Corporation
    tedizolid phosphate 200 mg / 4 mL (4 mL INJECTION) $2294.2200 VA FSS
  • SIVEXTRO (1)
    		•  Merck Sharp & Dohme Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue